A new study published in the Journal of the American Medical Association has found that women are more likely to suffer from failing metal-on-metal hip implants, such as the Stryker Rejuvenate and Stryker ABG II modular hip replacement systems. The study involved 35,000 women with several different types of all-metal hip replacements.
Funded by the U.S. Food and Drug Administration, researchers found that women are 30% more likely to require revision surgery to fix metal-on-metal hip replacement side effects. Co-author Dr. Art Sedrakyan proposed women could be at a higher risk complications from failing implants because they require smaller devices that are more susceptible to breaking or dislocating.
Stryker issued a Rejuvenate and ABG II recall after studies showed the hip implants were failing at a higher rate than expected. The metal stem and neck components could rub together and wear down over time, leading to an increased risk of tissue damage, limited mobility and metal poisoning from metal debris entering the blood stream.